October 4, 2019 – RenalGuard Therapy was found to be superior to the POSEIDON method in preventing contrast-induced ...
TCT
This channel contains news about the annual Transcatheter Cardiovascular Therapeutics (TCT) conference presented by the Cardiovascular Research Foundation (CRF). It includes coverage from the annual meeting and links CRF news. TCT is the premier conference for the subspecialty of interventional cardiology, including the new subspecialty areas of transcatheter structural heart procedures.
October 04, 2019
October 3, 2019 – Five-year results from the PARTNER 2A Trial found patients with severe aortic stenosis (AS) and ...
October 03, 2019
October 3, 2019 – Five-year data from the EXCEL Trial showed patients with left main coronary disease treated with ...
October 03, 2019Sponsored Content
Blog | Enterprise Imaging
The optimal delivery of cardiac care is evolving rapidly. A growing number of patients combined with innovative new ...
November 03, 2022
October 3, 2019 – The three-year results from the COAPT Trial demonstrated that reducing severe secondary mitral ...
October 03, 2019
October 2, 2019 – The first randomized trial to compare the safety and efficacy of the new Boston Scientific Acurate neo ...
October 02, 2019
October 2, 2019 – The Abbott Portico FDA investigational device exemption (IDE) study found that 30-day safety and one ...
October 02, 2019
September 30, 2019 – The first randomized trial to compare a durable polymer drug-eluting stent to a polymer-free drug ...
September 30, 2019
September 30, 2019 — A biodegradable polymer everolimus-eluting stent (BP-EES) followed by four months of dual ...
September 30, 2019
September 30, 2019 – Data from the EVOLVE Short DAPT study found that shortened three-month dual antiplatelet therapy ...
September 30, 2019
September 27, 2019 — Ancora Heart Inc. announced results from an interim analysis of heart failure patients treated in ...
September 27, 2019
September 27, 2019 — Abiomed’s newest heart pump, the Impella 5.5 with SmartAssist, has received U.S. Food and Drug ...
September 27, 2019
September 27, 2019 — EchoPixel introduced what it calls the first-ever intraoperative software to provide naked-eye ...
September 27, 2019
September 26, 2019 — New data from the Phase IV independent TWILIGHT trial showed Brilinta (ticagrelor) monotherapy redu ...
September 26, 2019
September 24, 2019 – Medtronic announced U.S. Food and Drug Administration (FDA) approval and U.S. launch of the Evolut ...
September 24, 2019
There was a 77 percent increase in survival in cardiogenic shock patients treated using a new protocol in the National ...
September 22, 2019